Characteristics of the samples included in the study
| Cancer | Subtype | Number | Sex (% male) | Age (mean/SD) | Stage (N) | ||
| I | II | III | |||||
| Bladder | Urothelial carcinoma | 22 | 55 | 63.1 (12.8) | 8 | 14 | – |
| Breast | Invasive ductal carcinoma | 22 | 0 | 46.3 (5.4) | – | – | 22 |
| Brain | Astrocytoma | 22 | 27 | 47.1 (8.7) | – | – | – |
| Cervical | Cervix uteri carcinoma | 22 | 0 | 50.1 (8.1) | 22 | – | – |
| Colorectal | Adenocarcinoma | 22 | 41 | 57.8 (5.9) | – | 16 | 6 |
| Kidney | Kidney renal papillary cell carcinoma | 22 | 23 | 57.5 (5.2) | 9 | 13 | – |
| Liver | Hepatocellular carcinoma | 22 | 41 | 56.7 (7.4) | – | 15 | 5 |
| Lung | Small and non-small cell | 44 | 45 | 57.6 (6.3) | – | 22 | 22 |
| Oesophagus | Squamous cell carcinoma | 22 | 59 | 61.4 (8.9) | – | 22 | – |
| Osteosarcoma | Steoblastic osteosarcoma | 22 | 23 | 40.4 (6) | – | 22 | – |
| Ovarian | Epithelial | 22 | 0 | 53.7 (6.6) | 22 | – | – |
| Pancreas | Ductal adenocarcinoma | 22 | 55 | 62.7 (6.1) | – | 22 | – |
| Prostate | Adenocarcinoma | 22 | 100 | 67.4 (8) | 7 | 15 | – |
| Stomach | Adenocarcinoma | 22 | 55 | 69.2 (5.8) | 13 | 9 | – |
| Testis | Seminoma | 22 | 100 | 52.2 (7.1) | – | 22 | – |
| Thyroid | Medullary thyroid cancer | 22 | 36 | 52.6 (7) | – | 22 | – |
| Uterus | Endometrial cancer | 22 | 0 | 52 (5.6) | 17 | 5 | – |
| Normal | – | 22 | 100 | 59.6 (7.2) | – | – | – |
| Normal | – | 22 | 0 | 50.2 (6) | – | – | – |